Relationships of N-Terminal Pro-B-Natriuretic Peptide and Cardiac Troponin T to Left Ventricular Mass and Function and Mortality in Asymptomatic Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 50, Issue 6, 2007, Pages 1009-1019

  Satyan, Sangeetha ^a   Light, Robert P ^a   Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hemodialysis; left ventricular function; left ventricular mass; mortality; N Terminal pro B type natriuretic peptide (NT pro BNP); troponin T

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DEVICE; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS PATIENT; HOME MONITORING; HUMAN; HYPERTENSION; IMMUNOASSAY; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; SURVIVAL ANALYSIS; TROPONIN T; VENTRICULAR DYSFUNCTION, LEFT;

EID: 36248997674     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.08.017     Document Type: Article

References (34)

1. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
2. Foley R.N., Parfrey P.S., Harnett J.D., et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5 (1995) 2024-2031
3. Foley R.N., Parfrey P.S., Harnett J.D., et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47 (1995) 186-192
4. Roberts M.A., Hare D.L., Ratnaike S., et al. Cardiovascular biomarkers in CKD: Pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 48 (2006) 341-360
5. Iliou M.C., Fumeron C., Benoit M.O., et al. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) Study. Am J Kidney Dis 42 (2003) 513-523
6. Mallamaci F., Zoccali C., Parlongo S., et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 40 (2002) 68-75
7. DeFilippi C., Wasserman S., Rosanio S., et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 290 (2003) 353-359
8. Havekes B., van Manen J.G., Krediet R.T., et al. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 47 (2006) 823-829
9. Kanwar M., Hashem M., Rosman H., et al. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients. Am J Cardiol 98 (2006) 1283-1287
10. Dierkes J., Domrose U., Westphal S., et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102 (2000) 1964-1969
11. Ooi D.S., Zimmerman D., Graham J., et al. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 47 (2001) 412-417
12. Apple F.S., Murakami M.M., Pearce L.A., et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106 (2002) 2941-2945
13. Khan N.A., Hemmelgarn B.R., Tonelli M., et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis. Circulation 112 (2005) 3088-3096
14. Rosner M.H. Measuring risk in end-stage renal disease: Is N-terminal pro brain natriuretic peptide a useful marker?. Kidney Int 71 (2007) 481-483
15. Madsen L.H., Ladefoged S., Corell P., et al. N-Terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 71 (2007) 548-554
16. Zoccali C., Mallamaci F., Benedetto F.A., et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12 (2001) 1508-1515
17. Naganuma T., Sugimura K., Wada S., et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22 (2002) 437-444
18. Sommerer C., Beimler J., Schwenger V., et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 37 (2007) 350-356
19. Fernandez-Reyes M.J., Mon C., Heras M., et al. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. J Nephrol 17 (2004) 721-727
20. Apple F.S., Murakami M.M., Pearce L.A., et al. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50 (2004) 2279-2285
21. Iliou M.C., Fumeron C., Benoit M.O., et al. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) Study. Nephrol Dial Transplant 16 (2001) 1452-1458
22. Mallamaci F., Zoccali C., Parlongo S., et al. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney Int 62 (2002) 1884-1890
23. Nishikimi T., Futoo Y., Tamano K., et al. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery disease. Am J Kidney Dis 37 (2001) 1201-1208
24. Zeng C., Wei T., Jin L., et al. Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients. Intern Med J 36 (2006) 552-557
25. Cataliotti A., Malatino L.S., Jougasaki M., et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 76 (2001) 1111-1119
26. Agarwal R., Andersen M.J., Bishu K., et al. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 69 (2006) 900-906
27. Agarwal R., Brim N.J., Mahenthiran J., et al. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 47 (2006) 62-68
28. Zoccali C., Benedetto F.A., Mallamaci F., et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 12 (2001) 2768-2774
29. Nunez E., Arnett D.K., Benjamin E.J., et al. Optimal threshold value for left ventricular hypertrophy in blacks: The Atherosclerosis Risk in Communities Study. Hypertension 45 (2005) 58-63
30. Zoccali C., Benedetto F.A., Tripepi G., et al. Left ventricular systolic function monitoring in asymptomatic dialysis patients: A prospective cohort study. J Am Soc Nephrol 17 (2006) 1460-1465
31. de Simone G., Devereux R.B., Roman M.J., et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 23 (1994) 1444-1451
32. Devereux R.B., Roman M.J., Palmieri V., et al. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Losartan Intervention For Endpoint reduction in hypertension. J Hypertens 18 (2000) 1129-1138
33. Osajima A., Okazaki M., Tamura M., et al. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease. Nephron 92 (2002) 832-839
34. Jourdain P., Jondeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP Multicenter Study. J Am Coll Cardiol 49 (2007) 1733-1739